Acromegaly: IGF-1, the glucose load and the face that changed
- Diagnostic test
Acromegaly changes a face so slowly that family and doctors miss it for years. A blood test called IGF-1 catches it, and a sugar drink confirms it.
See it in 3D: Pituitary gland · Sella turcica
What it is
Acromegaly is the result of growth hormone (GH) excess after the growth plates have closed; before closure it causes gigantism. Almost all cases come from a GH-secreting pituitary adenoma, most of them macroadenomas by the time of diagnosis; ectopic GHRH secretion is rare. GH acts largely through insulin-like growth factor 1 (IGF-1), made in the liver. The workup screens with IGF-1, confirms with an oral glucose tolerance test that fails to suppress GH, images the pituitary, and looks for the complications that shorten life: diabetes, hypertension, cardiomyopathy, sleep apnoea and colon polyps.
How to read the result
- IGF-1 above the age- and sex-adjusted range is the screening test; it reflects GH over the previous weeks.
- Confirmation: GH that does not fall below the assay cut-off (commonly 1 µg/L, or 0.4 µg/L with sensitive assays) during an oral glucose tolerance test.
- IGF-1 is falsely low in liver disease, malnutrition, poorly controlled diabetes, hypothyroidism and with oral oestrogen; it is normally high in puberty and pregnancy.
- A random GH is not diagnostic: healthy pulses and stress can make it high.
- Clues: larger hands and feet (rings and shoes no longer fit), coarse face, jaw growth with gaps between teeth, sweating, carpal tunnel syndrome, headaches and joint pain.
- Diagnosis is typically delayed by several years; comparing old photographs is a useful bedside test.
- Acromegaly can be part of an inherited syndrome (MEN1, Carney complex, AIP mutation), especially in young patients.
How it is done
- Suspect it from the features, or from an incidental pituitary mass.
- Measure IGF-1 and read it against the range for age and sex.
- IGF-1 high or equivocal: oral glucose tolerance test with timed GH samples.
- GH not suppressed: pituitary MRI with contrast.
- Test the rest of the pituitary (prolactin, cortisol, thyroid, gonadal axis) and visual fields if the tumour reaches the chiasm.
- Screen complications: glucose and HbA1c, blood pressure, echocardiogram, sleep study, colonoscopy and thyroid examination.
Reading IGF-1 and the glucose-suppressed GH together
| IGF-1 | GH after glucose | Meaning |
|---|---|---|
| High | Not suppressed | Acromegaly: image the pituitary |
| Normal | Suppressed | Acromegaly excluded |
| High | Suppressed | Puberty, pregnancy, assay problem; repeat or reconsider |
| Normal or low | Not suppressed | Uncontrolled diabetes, liver or kidney failure, malnutrition, anorexia, oral oestrogen |
Common pitfalls
- The glucose test is hard to read in uncontrolled diabetes, kidney or liver failure and anorexia: GH can fail to suppress without acromegaly.
- During treatment with a GH receptor antagonist, GH rises and the GH assay is unreliable: monitor IGF-1 only.
- «Pseudoacromegaly» (coarse features from insulin resistance or drugs) has a normal IGF-1.
Next step / Initial management
- IGF-1 first; glucose-suppressed GH to confirm; pituitary MRI only after biochemical confirmation.
- Transsphenoidal surgery is the first-line treatment for most patients; cure is judged on IGF-1 and GH about three months after surgery.
- Not cured or not operable: somatostatin analogues, a GH receptor antagonist, sometimes cabergoline, and radiotherapy.
- Refer every suspected case to endocrinology and an experienced pituitary surgeon.
Common traps
- A random GH confirms or excludes acromegaly: GH is pulsatile, so a single random value can do neither.
- IGF-1 can be read against the adult range in anyone: in a teenager or pregnant woman the adult range does not apply.
- An adenoma on MRI confirms acromegaly: going straight to MRI without biochemical confirmation finds non-functioning incidental adenomas.
- GH tracks control on a GH receptor antagonist: it does not, so GH is not monitored in a patient on this drug.
- Treating the tumour is the whole job: the heart, sleep apnoea and colon screening decide survival and must not be forgotten.
Test yourself
Think of the answer, then tap the question to see it.
Why is IGF-1, rather than a random GH, the screening test for acromegaly?
GH is secreted in pulses and varies minute to minute; IGF-1 integrates GH action over weeks and is stable.
What is the principle behind the oral glucose tolerance test in acromegaly?
Suspected excess is tested by suppression: glucose normally switches GH off, but an autonomous adenoma keeps secreting.
A man with poorly controlled diabetes has a normal IGF-1 but GH fails to suppress after glucose. Does he have acromegaly?
Probably not: uncontrolled diabetes can blunt GH suppression. A normal IGF-1 argues against acromegaly.
Which value should be used to monitor a patient treated with a GH receptor antagonist, and why?
IGF-1. The drug blocks GH action, so GH itself rises and is measured unreliably.
Elsewhere in DurgiPedia
- Growth hormone and IGF-1
- Somatotroph PitNET: gigantism and acromegaly
- Pituitary neuroendocrine tumours (PitNETs): overview
Connections
See it in 3D2
The structures of Durgical's 3D anatomy where it is found.
Educational content; it does not replace a medical assessment and is not a clinical instruction. For confusion, persistent vomiting with diabetes, fainting or very low blood pressure in someone who takes or has stopped glucocorticoids, go to an emergency department at once.
Sources: Acromegaly (StatPearls (NCBI Bookshelf), 2023); Pituitary Adenoma (StatPearls (NCBI Bookshelf), 2025); Imaging of the Pituitary Gland (StatPearls (NCBI Bookshelf), 2023).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
